A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene increases the risk of endometrial carcinoma

References

• Abd Elmageed ZY, Naura AS, Errami Y, Zerfaoui M. 2012. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport. Cellular Signalling 24:1–8.
   PubMed Web of Science ®Google Scholar
• Alanazi M, Pathan AAK, Arifeen Z, Shaik JP, Alabdulkarim HA, Semlali A, et al. 2013. Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population. PLoS One 8:e85541.
   PubMed Web of Science ®Google Scholar
• Alhadheq AM, Purusottapatnam Shaik J, Alamri A, Aljebreen AM, Alharbi O, Almadi MA, et al. 2016. The effect of Poly(ADP-ribose) polymerase-1 gene 3′Untranslated region polymorphism in colorectal cancer risk among saudi cohort. Disease Markers 2016:8289293.
   PubMed Web of Science ®Google Scholar
• Anil S, Gopikrishnan PB, Basheer AB, Vidyullatha BG, Alogaibi YA, Chalisserry EP, et al. 2016. Association of poly (ADP-Ribose) polymerase 1 variants with oral squamous cell carcinoma susceptibility in a South Indian population. Asian Pac J Cancer Prev 17:4107–4111.
   PubMedGoogle Scholar
• Bashir K, Sarwar R, Saeed S, Mahjabeen I, Kayani MA. 2018. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma. PLoS One 13:e0199007.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. 2016. Cancer statistics in China, 2015. A Cancer Journal for Clinicians 66:115–132.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhuo Z, Zhao P, Zhu J, Xin Y, Zhang J, et al. 2019. PARP1 gene polymorphisms and neuroblastoma susceptibility in Chinese children. Journal of Cancer 10:4159–4164.
   PubMed Web of Science ®Google Scholar
• Cui NH, Qiao C, Chang XK, Wei L. 2017. Associations of PARP-1 variant rs1136410 with PARP activities, oxidative DNA damage, and the risk of age-related cataract in a Chinese Han population: a two-stage case-control analysis. Gene 600:70–76.
   PubMed Web of Science ®Google Scholar
• Eritja N, Yeramian A, Chen BJ, Llobet-Navas D, Ortega E, Colas E, et al. 2017. Endometrial carcinoma: specific targeted pathways. Advances in Experimental Medicine and Biology 943:149–207.
   PubMed Web of Science ®Google Scholar
• Guillot C, Favaudon V, Herceg Z, Sagne C, Sauvaigo S, Merle P, et al. 2014. PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models. BMC Cancer 14:603–2407.
   PubMed Web of Science ®Google Scholar
• Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, et al. 2004. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Research 64:4378–4384.
   PubMed Web of Science ®Google Scholar
• Khan AU, Mahjabeen I, Malik MA, Hussain MZ, Khan S, Kayani MA. 2019. Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study. PLoS One 14:e0223882.
   PubMed Web of Science ®Google Scholar
• Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643–649.
   PubMed Web of Science ®Google Scholar
• Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, et al. 2009. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiology, Biomarkers and Prevention 18:204–214.
   PubMed Web of Science ®Google Scholar
• Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, et al. 2004. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Research 64:6344–6348.
   PubMed Web of Science ®Google Scholar
• Masutani M, Nakagama H, Sugimura T. 2005. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cellular and Molecular Life Sciences 62:769–783.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 16:1215.
   PubMed Web of Science ®Google Scholar
• Ray Chaudhuri A, Nussenzweig A. 2017. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nature Reviews. Molecular Cell Biology 18:610–621.
   PubMed Web of Science ®Google Scholar
• Roszak A, Lianeri M, Sowińska A, Jagodziński PP. 2013. Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian women. Molecular Diagnosis and Therapy 17:239–245.
   PubMed Web of Science ®Google Scholar
• Schneiderova M, Naccarati A, Pardini B, Rosa F, Gaetano CD, Jiraskova K, et al. 2017. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. Mutagenesis 32:533–542.
   PubMed Web of Science ®Google Scholar
• Shibata A, Kamada N, Masumura K, Nohmi T, Kobayashi S, Teraoka H, et al. 2005. Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent. Oncogene 24:1328–1337.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. 2013. Cancer statistics, 2013. A Cancer Journal for Clinicians 63:11–30.
   PubMed Web of Science ®Google Scholar
• Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, et al. 2008. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29:2132–2138.
   PubMed Web of Science ®Google Scholar
• Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, et al. 2012. The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis 33:581–586.
   PubMed Web of Science ®Google Scholar
• Vale CL, Tierney J, Bull SJ, Symonds PR. 2012. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst Rev 2012:CD003915.
   PubMed Web of Science ®Google Scholar
• Wang HT, Gao Y, Zhao YX, Yu H, Wang TL, Bai L, et al. 2014. PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer. Genetic Testing and Molecular Biomarkers 18:736–740.
   PubMed Web of Science ®Google Scholar
• Wang XG, Wang ZQ, Tong WM, Shen Y. 2007. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochemical and Biophysical Research Communications 354:122–126.
   PubMed Web of Science ®Google Scholar
• Yu P, Liu YP, Zhang JD, Qu XJ, Jin B, Zhang Y. 2015. Correlation between PARP-1 Val762Ala polymorphism and the risk of lung cancer in a Chinese population. Tumour Biology 36:177–181.
   PubMedGoogle Scholar
• Zhai L, Li S, Li H, Zheng Y, Lang R, Fan Y, et al. 2015. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients. Int J Clin Exp Pathol 8:7059–7071.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W. 2009. PARP-1 Val762Ala polymorphism, CagA + H. pylori infection and risk for gastric cancer in Han Chinese population. Molecular Biology Reports 36:1461–1467.
   PubMed Web of Science ®Google Scholar